Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical Evidence.
Saved in:
| Title: | Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical Evidence. |
|---|---|
| Authors: | Abu Suleiman A; Department of Internal Medicine, York and Scarborough Teaching Hospitals NHS Trust, York YO31 8HE, UK., Quagliariello V; Division of Cardiology, Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale, 80131 Naples, Italy., Spadafora L; Division of Cardiology, Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale, 80131 Naples, Italy., Russo F; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.; Division of Cardiology, Sant'Andrea University Hospital, 00189 Rome, Italy., Maurea N; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy. |
| Source: | Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2026 May 27; Vol. 19 (6). Date of Electronic Publication: 2026 May 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1424-8247 |
|---|---|
| DOI: | 10.3390/ph19060833 |
